Showing results (1381-1390 of 2,024) with videos related to

Sort By:
Pageof 203
Plos Medicine|August 24, 2007
Defining childhood severe falciparum malaria for intervention studiesPhilip Bejon, James A Berkley, Tabitha Mwangi, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|February 21, 2015
[New trial designs and potential therapies for pulmonary artery hypertension]Mardi Gomberg-Maitland, Todd M Bull, Rajeev Saggar, et al.
ERJ Open Research|April 26, 2021
Lumacaftor/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patientsAnne H Neerincx, Katrine Whiteson, Joann L Phan, et al.
Pharmacogenetics|November 20, 2002
The effectiveness of hydroxy-methylglutaryl coenzyme A reductase inhibitors (statins) in the elderly is not influenced by apolipoprotein E genotypeAnke-Hilse Maitland-van der Zee, Bruno H Stricker, Olaf H Klungel, et al.
Frontiers in Genetics|November 16, 2020
Impact of a Gap Junction Protein Alpha 4 Variant on Clinical Disease Phenotype in F508del Homozygous Patients With Cystic FibrosisTabea Horn, Michael Ludwig, Olaf Eickmeier, et al.
Journal of the American College of Cardiology|December 21, 2013
New trial designs and potential therapies for pulmonary artery hypertensionMardi Gomberg-Maitland, Todd M Bull, Rajeev Saggar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2023
Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150René Bruno, Mathilde Marchand, Kenta Yoshida, et al.
The Pharmacogenomics Journal|March 3, 2010
Single nucleotide polymorphisms in genes that are associated with a modified response to statin therapy: the Rotterdam StudyC E de Keyser, M Eijgelsheim, A Hofman, et al.
Pageof 203